153 related articles for article (PubMed ID: 9369958)
1. Characterization of a 60-kDa cell surface-associated transforming growth factor-beta binding protein that can interfere with transforming growth factor-beta receptor binding.
Piek E; Franzén P; Heldin CH; ten Dijke P
J Cell Physiol; 1997 Dec; 173(3):447-59. PubMed ID: 9369958
[TBL] [Abstract][Full Text] [Related]
2. The first stage of transforming growth factor beta1 activation is release of the large latent complex from the extracellular matrix of growth plate chondrocytes by matrix vesicle stromelysin-1 (MMP-3).
Maeda S; Dean DD; Gomez R; Schwartz Z; Boyan BD
Calcif Tissue Int; 2002 Jan; 70(1):54-65. PubMed ID: 11907708
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of transforming growth factor (TGF) beta1 type II receptor restores TGF-beta1 sensitivity and signaling in human prostate cancer cells.
Guo Y; Kyprianou N
Cell Growth Differ; 1998 Feb; 9(2):185-93. PubMed ID: 9486855
[TBL] [Abstract][Full Text] [Related]
4. Characterization and regulation of the latent transforming growth factor-beta complex secreted by vascular pericytes.
Marra F; Bonewald LF; Park-Snyder S; Park IS; Woodruff KA; Abboud HE
J Cell Physiol; 1996 Mar; 166(3):537-46. PubMed ID: 8600157
[TBL] [Abstract][Full Text] [Related]
5. Growth plate chondrocytes store latent transforming growth factor (TGF)-beta 1 in their matrix through latent TGF-beta 1 binding protein-1.
Pedrozo HA; Schwartz Z; Gomez R; Ornoy A; Xin-Sheng W; Dallas SL; Bonewald LF; Dean DD; Boyan BD
J Cell Physiol; 1998 Nov; 177(2):343-54. PubMed ID: 9766531
[TBL] [Abstract][Full Text] [Related]
6. Transforming growth factor-beta receptor expression on human skin fibroblasts: dimeric complex formation of type I and type II receptors and identification of glycosyl phosphatidylinositol-anchored transforming growth factor-beta binding proteins.
Tam BY; Philip A
J Cell Physiol; 1998 Sep; 176(3):553-64. PubMed ID: 9699508
[TBL] [Abstract][Full Text] [Related]
7. Modulation of sensitivity to transforming growth factor-beta 1 (TGF-beta 1) and the level of type II TGF-beta receptor in LNCaP cells by dihydrotestosterone.
Kim IY; Zelner DJ; Sensibar JA; Ahn HJ; Park L; Kim JH; Lee C
Exp Cell Res; 1996 Jan; 222(1):103-10. PubMed ID: 8549651
[TBL] [Abstract][Full Text] [Related]
8. The conventional transforming growth factor-beta (TGF-beta) receptor type I is not required for TGF-beta 1 signaling in a human prostate cancer cell line, LNCaP.
Kim IY; Zelner DJ; Lee C
Exp Cell Res; 1998 May; 241(1):151-60. PubMed ID: 9633523
[TBL] [Abstract][Full Text] [Related]
9. Platelet factor 4 selectively inhibits binding of TGF-beta 1 to the type I TGF-beta 1 receptor.
Whitson RH; Wong WL; Itakura K
J Cell Biochem; 1991 Sep; 47(1):31-42. PubMed ID: 1658013
[TBL] [Abstract][Full Text] [Related]
10. TGF-beta-induced apoptosis is mediated by the adapter protein Daxx that facilitates JNK activation.
Perlman R; Schiemann WP; Brooks MW; Lodish HF; Weinberg RA
Nat Cell Biol; 2001 Aug; 3(8):708-14. PubMed ID: 11483955
[TBL] [Abstract][Full Text] [Related]
11. Genetic change in transforming growth factor beta (TGF-beta) receptor type I gene correlates with insensitivity to TGF-beta 1 in human prostate cancer cells.
Kim IY; Ahn HJ; Zelner DJ; Shaw JW; Sensibar JA; Kim JH; Kato M; Lee C
Cancer Res; 1996 Jan; 56(1):44-8. PubMed ID: 8548772
[TBL] [Abstract][Full Text] [Related]
12. Decreased transforming growth factor-beta response and binding in insulin-independent teratoma-derived cell lines with increased tumorigenic properties.
Serrero G; Zhou J; Mills D; LePak N
J Cell Physiol; 1991 Dec; 149(3):503-11. PubMed ID: 1660484
[TBL] [Abstract][Full Text] [Related]
13. Further studies of the role of transforming growth factor-beta in human B cell function.
Kehrl JH; Taylor AS; Delsing GA; Roberts AB; Sporn MB; Fauci AS
J Immunol; 1989 Sep; 143(6):1868-74. PubMed ID: 2550546
[TBL] [Abstract][Full Text] [Related]
14. Restoration of transforming growth factor beta signaling pathway in human prostate cancer cells suppresses tumorigenicity via induction of caspase-1-mediated apoptosis.
Guo Y; Kyprianou N
Cancer Res; 1999 Mar; 59(6):1366-71. PubMed ID: 10096572
[TBL] [Abstract][Full Text] [Related]
15. Subtypes of betaglycan and of type I and type II transforming growth factor-beta (TGF-beta) receptors with different affinities for TGF-beta 1 and TGF-beta 2 are exhibited by human placental trophoblast cells.
Mitchell EJ; Fitz-Gibbon L; O'Connor-McCourt MD
J Cell Physiol; 1992 Feb; 150(2):334-43. PubMed ID: 1310325
[TBL] [Abstract][Full Text] [Related]
16. Lack of the latent transforming growth factor beta binding protein in malignant, but not benign prostatic tissue.
Eklöv S; Funa K; Nordgren H; Olofsson A; Kanzaki T; Miyazono K; Nilsson S
Cancer Res; 1993 Jul; 53(13):3193-7. PubMed ID: 7686449
[TBL] [Abstract][Full Text] [Related]
17. Expression of truncated latent TGF-beta-binding protein modulates TGF-beta signaling.
Mazzieri R; Jurukovski V; Obata H; Sung J; Platt A; Annes E; Karaman-Jurukovska N; Gleizes PE; Rifkin DB
J Cell Sci; 2005 May; 118(Pt 10):2177-87. PubMed ID: 15870109
[TBL] [Abstract][Full Text] [Related]
18. Growth factor-binding sequence in human alpha2-macroglobulin targets the receptor-binding site in transforming growth factor-beta.
Arandjelovic S; Freed TA; Gonias SL
Biochemistry; 2003 May; 42(20):6121-7. PubMed ID: 12755614
[TBL] [Abstract][Full Text] [Related]
19. Adenoviral delivery of an antisense RNA complementary to the 3' coding sequence of transforming growth factor-beta1 inhibits fibrogenic activities of hepatic stellate cells.
Arias M; Lahme B; Van de Leur E; Gressner AM; Weiskirchen R
Cell Growth Differ; 2002 Jun; 13(6):265-73. PubMed ID: 12114216
[TBL] [Abstract][Full Text] [Related]
20. Retinoids potentiate transforming growth factor-beta activity in bovine endothelial cells through up-regulating the expression of transforming growth factor-beta receptors.
Yoshizawa M; Miyazaki H; Kojima S
J Cell Physiol; 1998 Sep; 176(3):565-73. PubMed ID: 9699509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
